Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program

This bill would establish maximum prices for certain prescription drugs in Minnesota, based on prices set by the federal Medicare Drug Price Negotiation Program. It prohibits drug manufacturers from charging more than this maximum price and requires health plans and pharmacy benefit managers to reimburse pharmacies at least the maximum price or the national average drug acquisition cost, whichever is higher. The bill also includes penalties for manufacturers who withdraw drugs from the state to avoid these price limits.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text